Waxman-Hatch changes are on the way

A survey conducted by 3 Axis Advisors revealed potential impacts of the Inflation Reduction Act’s Medicare Drug Price Negotiation Program.

Todd Eury of the Pharmacy Podcast Network is joined by Josh Bolin of the NABP to talk about DSCSA, what benefits it will provide, and how to make sure your pharmacy is ready when it goes into effect this November.

The Federal Trade Commission released its second interim staff report on industry-leading pharmacy benefit managers and their practices specifically regarding specialty drugs.

This special Over the Counter episode, brought to you by Total Pharmacy® and Omega Pharmacy Group, dives into how to navigate the business of independent pharmacy and get ahead of key policy changes.

The lawsuit alleges that the company knowingly violated both the Controlled Substances Act and the False Claims Act.

The American Pharmacists Association announced the inclusion of pharmacist-backed PBM reform in Congress’ end of the year spending package.